Medical Eligibility Criteria for Contraceptive Use (5th edition)

subcutaneous depot medroxyprogesterone acetate safety systematic review, DMPA-SC versus DMPA-IM safety comparison women, depot medroxyprogesterone bone mineral density effect, DMPA subcutaneous 104mg safety obesity endometriosis HIV, progestogen-only injectable contraceptive WHO medical eligibility criteria, DMPA-SC weight gain bleeding patterns adverse effects, subcutaneous DMPA adolescent adult bone density comparison, depot medroxyprogesterone acetate endometriosis pain treatment safety, DMPA contraceptive efficacy obese women subcutaneous injection, WHO MEC 5th edition DMPA-SC safety review Dragoman